Last reviewed · How we verify
NCT03218891
Cardiac Rehabilitation in Patients With Refractory Angina
NA trial testing Cardiac Rehabilitation in Refractory Angina in 72 participants. Completed in 1 February 2022.
28 July 2020
Quick facts
| Lead sponsor | Hospital Israelita Albert Einstein |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 72 |
| Start date | 1 January 2016 |
| Primary completion | 28 July 2020 |
| Estimated completion | 1 February 2022 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Cardiac Rehabilitation
Conditions studied
- Refractory Angina — all drugs for Refractory Angina →
Sponsor
Hospital Israelita Albert Einstein
Who can join
Adults 45 to 75, any sex, with Refractory Angina. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the safety and feasibility of cardiovascular rehabilitation in Patients with refractory angina, evaluate the effect of cardiovascular rehabilitation in patients with angina Refractory, by maximal oxygen consumption (VO2max) and global myocardial ischemic load by Stress Echocardiography; To evaluate the presence of myocardial injury, caused by physical stress, through ultra-sensitive troponin after sessions of aerobic physical activity, evaluating the behavior during the training period; To evaluate the effect of rehabilitation on the modulation of sympathetic activity and inflammation, muscular blood flow and lipid metabolism; To evaluate of the effect of rehabilitation on ventricular function through Stress echocardiography; Detection of ischemic episodes and arrhythmias identified during the Rehabilitation sessions through external cardiac monitoring (telemetry); Evaluate the quality of life assessment through the SF-36 questionnaire, Canadian Cardiovascular Society, the number of symptomatic episodes of ischemia, daily sublingual nitrate intake.
Publications & conference data
6 peer-reviewed publications reference this trial (live from Europe PMC):
-
Does Myocardial Injury Occur After an Acute Aerobic Exercise Session in Patients with Refractory Angina?
Montenegro CGSP, Dourado LOC, Jordão CP, Vieira MLC, et al · · 2022 · cited 4× · PMID 36453766 · DOI 10.36660/abc.20210564 -
Cardiopulmonary exercise test in patients with refractory angina: functional and ischemic evaluation.
de Assumpção CRA, do Prado DML, Jordão CP, Dourado LOC, et al · · 2022 · cited 4× · PMID 35134662 · DOI 10.1016/j.clinsp.2021.100003 -
Safety and Efficacy of Exercise-based Cardiac Rehabilitation in Patients with Refractory Angina.
Dourado LOC, Jordão CP, Vieira MLC, Gowdak LHW, et al · · 2025 · PMID 41637323 · DOI 10.36660/abc.20250331 -
“Safety and Efficacy of Exercise-based cardiac rehabilitation in patients with refractory angina: a randomized, controlled trial”
Dourado LOC, Jordão CP, Vieira MLC, Gowdak LHW, et al · · 2024 · DOI 10.1101/2024.08.08.24311708 -
In the Cardiac Rehabilitation Era, is There a "No-Option" Refractory Angina Patient?: A Case Report.
Dourado LOC, Jordão CP, Assumpção CRA, Matos LDNJ. · · 2023 · PMID 37878880 · DOI 10.36660/abc.20230007 -
Refractory Angina Referral to Cardiovascular Rehabilitation: A Neglected Patient.
Milani M, Milani JGPO, Cipriano Junior G. · · 2022 · PMID 36453767 · DOI 10.36660/abc.20220695
Verify or expand the search:
- PubMed search for NCT03218891
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cardiac Rehabilitation
Trials testing the same drug.
- NCT07095764 — Effects of In-Hospital Cardiac Rehabilitation and Manual Lymphatic Drainage in Acute Decompensated Heart Failure · NA · completed
- NCT06426914 — Clinical Pilates (CP) Exercises and Kinesiophobia in CABG · NA · completed
- NCT06552390 — Cardiac Rehabilitation for Inpatient Heart Transplant (HRN4HTx) · NA · completed
- NCT03394183 — Efficacy of Cardiac Rehab for Patients With Peripheral Artery Disease Versus Patients With Coronary Artery Disease · NA · withdrawn
- NCT03706105 — Integrating Stroke Survivors Into Cardiac Rehabilitation · NA · completed
Other recruiting trials for Refractory Angina
Currently open trials in the same condition.
- NCT07048808 — Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina. · Phase 2 · recruiting
- NCT05711849 — Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina · Phase 2 · recruiting
- NCT05492110 — Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microva · NA · recruiting
- NCT04606459 — COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina · NA · recruiting
- NCT01566175 — Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina · NA · recruiting
Other Hospital Israelita Albert Einstein trials
Trials by the same sponsor.
- NCT07447674 — ED Post-Discharge Digital Follow-Up: A Communication Comparison · NA · not yet recruiting
- NCT07398222 — Gastric Content in Fasting Volunteers and in Tirzepatide Users: an Observational and Cross-sectional Study · recruiting
- NCT07233837 — Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units · NA · recruiting
- NCT06726707 — COPPER: A Trial Evaluating Copper-based Products for Incontinence-associated Dermatitis · Phase 2, PHASE3 · withdrawn
- NCT07112846 — Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03218891 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Israelita Albert Einstein
- Last refreshed: 11 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03218891.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing